Cristina R. Ventura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cristina R. Ventura has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Gregory Wiedman
Department of Chemistry and Biochemistry
2 shared publications - Adam Kmeck
Department of Chemistry and Biochemistry, Seton Hall University, South Orange, NJ 07079, USA
1 shared publication - Robert J. Tancer
Department of Chemistry and Biochemistry Seton Hall University South Orange New Jersey USA
1 shared publication
Latest Publications
- 1 December 2021
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1863 (12) , 183759
Substituting azobenzene for proline in melittin to create photomelittin: A light-controlled membrane active peptide
- 1 December 2021
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1863 (12) , 183759
Substituting azobenzene for proline in melittin to create photomelittin: A light-controlled membrane active peptide
- Open Access
- 19 September 2020
- Published by MDPI AG in Antibiotics
- Vol. 9 (9) , 620
Synergies with and Resistance to Membrane-Active Peptides
Membrane-active peptides (MAPs) have long been thought of as the key to defeating antimicrobial-resistant microorganisms. Such peptides, however, may not be sufficient alone. In this review, we seek to highlight some of the common pathways for resistance, as well as some avenues for potential synergy. This discussion takes place considering resistance, and/or synergy in the extracellular space, at the membrane, and during interaction, and/or removal. Overall, this review shows that researchers require improved definitions of resistance and a more thorough understanding of MAP-resistance mechanisms. The solution to combating resistance may ultimately come from an understanding of how to harness the power of synergistic drug combinations.
- 19 September 2020
- Published by MDPI AG in Antibiotics
- Vol. 9 (9) , 620
Open AccessSynergies with and Resistance to Membrane-Active Peptides
Membrane-active peptides (MAPs) have long been thought of as the key to defeating antimicrobial-resistant microorganisms. Such peptides, however, may not be sufficient alone. In this review, we seek to highlight some of the common pathways for resistance, as well as some avenues for potential synergy. This discussion takes place considering resistance, and/or synergy in the extracellular space, at the membrane, and during interaction, and/or removal. Overall, this review shows that researchers require improved definitions of resistance and a more thorough understanding of MAP-resistance mechanisms. The solution to combating resistance may ultimately come from an understanding of how to harness the power of synergistic drug combinations.